- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03715088
Impacts of Resistance Training on Acute Secretion of Irisin in Obese Older and Young Adults
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Worldwide, the number of individuals living with obesity has doubled over the past thirty years. The growing prevalence of obesity is concerning as obesity is known to be one of the main risk factors for many chronic conditions, such as Type 2 diabetes and cardiovascular diseases. Therefore, it is important that the impact of different types of exercise are understood to properly prescribe exercise interventions to individuals living with obesity. Recently, there has been increased interest for a biologically active substances that are secreted during muscle contraction, myokines, regarding their effects on metabolism during exercise. Specifically, a novel myokine, named irisin, has caught the attention of numerous researchers. Irisin has been shown to play an important role in increasing energy expenditure, reducing body weight, and improving glucose metabolism by adipocyte metabolism. As of now, the majority of research has focused on irisin release during endurance activity; however, there is limited research on irisin secretion during resistance exercise training.
Statement of Objectives: The purpose of this pilot study is to first determine whether irisin secretion increases during an acute session of resistance exercise training with obese individuals; and second, to determine whether changes in irisin levels during an acute bout of resistance exercise training can be seen in different age groups for obese individuals.
Methodology: Fifteen young and fifteen old participants will be recruited via advertisement in the local newspaper, on radio stations, and on posters. Inclusion criteria include individuals aged between either 18-30 or 65-75 years old, classified as obese according to their BMI (>30 kg/m2), inactive defined as engaging in less than 150 minutes of moderate to vigorous aerobic exercise, not currently engaged in a resistance exercise training program, no previous diagnosis of Type 2 diabetes, and having no injuries or conditions that would prevent them from performing a resistance exercise training session.
Primary Outcome Measure: The primary outcome measure in this study will be the change in irisin levels during resistance exercise training. A validated enzyme immunoassay kit from Phoenix Pharmaceutical Inc. (EK-067-16) will be used to measure irisin. Our group already has experience with this equipment and these procedures, which has been validated.
Resistance Exercise Session: Participants will come for their first visit at which time they they will perform a test to determine their maximal strength [1-repetition maximal (1-RM)] for each exercise included in the program. During their second visit, participants will perform 10 different resistance exercises consisting of three sets of 8-10 repetitions, at 80% of 1-RM. A 60-second rest will occur between sets. This exercise protocol was selected based on literature that suggests that the protocol and the intensity do not enhance mitochondria biogenesis. Also, this protocol was shown to be well tolerated by obese and older individuals.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New Brunswick
-
Fredericton, New Brunswick, Canada, E3B 5A3
- University of New Brunswick - Kinesiology
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 18-35 or 60-75 years old
- Physically inactive (engaging in less than 150 minutes of moderate to vigorous aerobic exercise)
- No previous diagnosis of Type 2 diabetes
- Obese (BMI ≥30kg/m2)
Exclusion Criteria:
- BMI less than 30kg/m2
- History of Type 2 diabetes
- Physically active (engaging in atleast 150 minutes of moderate to vigorous aerobic exercise)
- Injury or condition that prevents performance of resistance training exercise.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Older Adults (BMI ≥30 kg/m2)
Individuals aged 65-75 living with obesity will perform the Resistance Training Intervention.
|
Participants will perform 10 different resistance exercises consisting of three sets of 8-10 repetitions, at 80% of 1-RM, separated by 60-second rest intervals between sets.
This exercise protocol was chosen based on literature that suggests that the protocol and intensity do not enhance mitochondria biogenesis.
Also, it was well tolerated by obese and older individuals.
|
Experimental: Younger Adults (BMI ≥30 kg/m2)
Individuals aged 18-30 living with obesity will perform Resistance Training Intervention.
|
Participants will perform 10 different resistance exercises consisting of three sets of 8-10 repetitions, at 80% of 1-RM, separated by 60-second rest intervals between sets.
This exercise protocol was chosen based on literature that suggests that the protocol and intensity do not enhance mitochondria biogenesis.
Also, it was well tolerated by obese and older individuals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Irisin
Time Frame: Baseline (0 minute), 15 minutes, 30 minutes, and 45 minutes during exercise and 45 minutes post exercise
|
The primary outcome is the change in irisin during an acute bout of resistance exercise training.
|
Baseline (0 minute), 15 minutes, 30 minutes, and 45 minutes during exercise and 45 minutes post exercise
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UNB Fredericton
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
-
Consorcio Centro de Investigación Biomédica en...Maimónides Biomedical Research Institute of Córdoba; Instituto de Salud Carlos... and other collaboratorsActive, not recruiting
-
University of HoustonBaylor College of MedicineCompleted
Clinical Trials on Resistance Training Intervention
-
Paracelsus Medical UniversityCompletedType 2 Diabetes MellitusAustria
-
University of BirminghamEuropean Commission; HUR LabsUnknownPhysical Activity | Frail Elderly Syndrome | FrailtyUnited Kingdom
-
University of Rhode IslandCompletedSarcopeniaUnited States
-
Allegheny Singer Research Institute (also known...Recruiting
-
University of HullCompletedObesity, Morbid
-
University of KasselCompleted
-
University of KasselUniversity of PotsdamCompleted
-
University of Alabama at BirminghamCompletedMusculoskeletal and Metabolic CrosstalkUnited States
-
University of Applied Sciences of Western SwitzerlandCompleted
-
University of BarcelonaCompleted